Wei Lin
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
-
- Vasculitis and related conditions
- Ferroptosis and cancer prognosis
Papers in
-
- Inflammasome and immune disorders 7
- RNA modifications and cancer 5
-
- Vasculitis and related conditions 19
- Co-authors
- Xiaodong Cheng (1 shared paper)Mark A. White (1 shared paper)Zhijie Xu (7 shared papers)Yuanliang Yan (7 shared papers)Chunlin Ou (6 shared papers)Xiangcheng Xiao (24 shared papers)Yong Zhong (19 shared papers)Ting Meng (20 shared papers)
- Journals
- Clinical and Experimental Medicine (6 papers)Frontiers in Immunology (3 papers)Journal of Hepatology (3 papers)OncoTargets and Therapy (2 papers)Immunologic Research (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Wei Lin
86 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 106
- Nephrology 150
- Pulmonary and Respiratory Medicine 284
- Immunology 152
- Infectious Diseases 132
- Rheumatology 96
Countries citing papers authored by Wei Lin
This map shows the geographic impact of Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lin more than expected).
Fields of papers citing papers by Wei Lin
This network shows the impact of papers produced by Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lin. The network helps show where Wei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 108 | |
| 2 | 2019 | 85 | |
| 3 | 2020 | 38 | |
| 4 | 2019 | 37 | |
| 5 | 2020 | 33 | |
| 6 | 2020 | 31 | |
| 7 | Expression of inflammasomes NLRP1, NLRP3 and AIM2 in different pathologic classification of lupus nephritis. | 2020 | 31 |
| 8 | 2020 | 30 | |
| 9 | 2021 | 29 | |
| 10 | 2016 | 26 | |
| 11 | 2020 | 26 | |
| 12 | 2021 | 25 | |
| 13 | 2010 | 24 | |
| 14 | 2019 | 23 | |
| 15 | 2023 | 21 | |
| 16 | 2019 | 21 | |
| 17 | 2022 | 20 | |
| 18 | 2024 | 20 | |
| 19 | 2020 | 19 | |
| 20 | 2019 | 18 |
About Wei Lin
Wei Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology, Surgery and Physiology, having authored 99 papers that have together received 1.1k indexed citations. Recurring topics across this work include Vasculitis and related conditions (19 papers), Renal Diseases and Glomerulopathies (9 papers), Liver Disease Diagnosis and Treatment (7 papers), Inflammasome and immune disorders (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Sarcoidosis and Beryllium Toxicity Research (6 papers), Organ Transplantation Techniques and Outcomes (6 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Nephrology (150 citations), Pulmonary and Respiratory Medicine (284 citations), Immunology (152 citations), Infectious Diseases (132 citations) and Rheumatology (96 citations). Wei Lin has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Xiaodong Cheng, Mark A. White, Zhijie Xu, Yuanliang Yan, Chunlin Ou, Xiangcheng Xiao, Yong Zhong, Ting Meng, Shuangshuang Zeng and Jie Wei. Their work appears in journals such as Clinical and Experimental Medicine, Frontiers in Immunology, Journal of Hepatology, OncoTargets and Therapy and Immunologic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.